Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott S, Raz I, Bonaca et al for the DECLARE–TIMI 58 Investigators
The New England Journal of Medicine Downloaded from nejm.org on November 12, 2018.
https://www.nejm.org/doi/full/10.1056/NEJMoa1812389